Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes
- 1 January 2003
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 63 (1) , 209-216
- https://doi.org/10.1046/j.1523-1755.2003.00736.x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Role of the Renin-Angiotensin System in Vascular DiseasesHypertension, 2001
- Pressure-induced expression of monocyte chemoattractant protein-1 through activation of MAP kinaseKidney International, 2001
- Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in ratsKidney International, 1999
- Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletionNephrology Dialysis Transplantation, 1999
- MYCOPHENOLIC ACID, AN INHIBITOR OF IMP DEHYDROGENASE THAT IS ALSO AN IMMUNOSUPPRESSIVE AGENT, SUPPRESSES THE CYTOKINE-INDUCED NITRIC OXIDE PRODUCTION IN MOUSE AND RAT VASCULAR ENDOTHELIAL CELLSTransplantation, 1995
- Cellular events in the evolution of experimental diabetic nephropathyKidney International, 1995
- Glomerular Expression and Cell Origin of Transforming Growth Factor-β1 in Anti-Glomerular Basement Membrane DiseaseThe Lancet Healthy Longevity, 1994
- Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat.Journal of Clinical Investigation, 1992
- Lymphocyte‐Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide DepletionScandinavian Journal of Immunology, 1991
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988